CMOs need to increase awareness of offerings, ISR reports

A “new set of leaders” emerged in the contract manufacturing organization (CMO) industry over the past year, though many remain unheard of, according to a recent report. Kate Hammeke, Vice President, Market Research, Industry Standard Research, told us drug product outsourcers are consistent in their prioritization of CMO selection attributes. “The same three attributes topped … Continued

Big Pharma CMOs capture strongest performance ratings for small molecule API manufacturing

Informing the pharmaceutical drug development, manufacturing and commercialization industry. Cary, NC – February 9, 2017 – The 2nd edition of Industry Standard Research’s (ISR’s) Small Molecule API Contract Manufacturer Quality Benchmarking report reveals that the top performing CMOs relative to expectations, and based off customer feedback on recent service encounters, are contract manufacturers with a drug … Continued

Regulatory history and reliable on-time delivery beat cost and capacity as the most important selection attributes for drug product CMOs

Informing the pharmaceutical drug development, manufacturing and commercialization industry. Cary, NC – February 8, 2017 – The 2nd edition of Industry Standard Research’s (ISR’s) Drug Product Contract Manufacturer Quality Benchmarking report reveals that buyers of outsourced drug product manufacturing services value a strong regulatory history and reliable on-time delivery more than low cost when selecting … Continued

Customer loyalty scores for biologic API contract manufacturers slip

Informing the pharmaceutical drug development, manufacturing and commercialization industry. Cary, NC – February 8, 2017 – The 2nd edition of Industry Standard Research’s (ISR’s) Biologic API Contract Manufacturer Quality Benchmarking report indicates that buyers of outsourced biologic API services are less loyal to the CMOs they use compared to one year ago. The report includes … Continued

ISR CUSTOMERS